Vertex Pharmaceuticals, Inc.
(NASDAQ : VRTX)

( )
VRTX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -16.36%57.710.0%$1498.86m
GILDGilead Sciences, Inc. -0.22%73.181.0%$1307.19m
AMGNAmgen, Inc. -1.78%222.401.3%$642.71m
NVAXNovavax, Inc. 4.47%48.17102.0%$586.24m
REGNRegeneron Pharmaceuticals, Inc. -4.33%545.212.5%$546.52m
VRTXVertex Pharmaceuticals, Inc. -6.48%266.501.9%$495.73m
BIIBBiogen, Inc. -2.84%295.871.6%$409.33m
ILMNIllumina, Inc. -0.08%354.413.5%$346.51m
SRNESorrento Therapeutics, Inc. 3.95%5.271.8%$307.12m
SGENSeattle Genetics, Inc. -2.59%151.736.1%$229.36m
ALXNAlexion Pharmaceuticals, Inc. 1.28%102.802.0%$224.52m
CODXCo-Diagnostics, Inc. -2.80%18.030.0%$192.65m
AAgilent Technologies, Inc. 1.37%86.141.6%$192.54m
MGNXMacroGenics, Inc. -6.82%23.646.2%$185.80m
BMRNBioMarin Pharmaceutical, Inc. 6.39%103.744.3%$158.47m

Company Profile

Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. It focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.